Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Types of Toxins01:36

Types of Toxins

3.6K
Humans continually engage with an environment rich in potentially harmful chemicals. These are introduced to our bodies through inhalation, ingestion, or skin contact. These chemicals exist in various forms, such as air and environmental pollutants, agricultural chemicals, organic solvents, and heavy metals.
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
3.6K
Toxic Reactions: Overview01:26

Toxic Reactions: Overview

4.1K
When toxic substances penetrate the human body, they disseminate to various tissues, undergoing metabolic changes. This process yields reactive metabolites that may covalently bind with specific target molecules, resulting in toxicity.
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
4.1K
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

379
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
379
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

271
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
271
Bioactivation and Tissue Toxicity01:25

Bioactivation and Tissue Toxicity

151
Bioactivation is a metabolic process that transforms less reactive substances into highly reactive metabolites, initiating tissue toxicity. This transformation can lead to various toxic effects, including carcinogenesis and teratogenesis. Reactive metabolites are classified into two main types: electrophiles and free radicals.Electrophiles are electron-deficient species and are produced primarily by the enzyme cytochrome P-450 during the metabolism of compounds containing carbon, nitrogen, or...
151
Toxicity Testing in Animals01:23

Toxicity Testing in Animals

200
Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...
200

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

N<sup>4</sup>-Acetylcytidine enhances synthetic mRNA translation yield and fidelity.

Nature·2026
Same author

Draft genome sequences of three non-O1/non-O139 <i>Vibrio cholerae</i> isolates from Lake Wonderwood near Seminole Beach, Florida.

Microbiology resource announcements·2026
Same author

FALCON: Closed-Loop Multi-Objective Optimization of Lipid Nanoparticles for Cell-Selective mRNA Delivery.

bioRxiv : the preprint server for biology·2026
Same author

Data resource profile: PharmaNet, the database for prescription drug dispensing in British Columbia, Canada.

International journal of population data science·2026
Same author

Dual-transcriptomic analysis of human nasal transcriptome and microbiome reveals host-bacteria associations in symptomatic respiratory infection.

BMC genomics·2026
Same author

Lipid nanoparticle composition directs systemic trafficking and tissue-specific T cell immunity after intramuscular injection.

Nature biomedical engineering·2026

Related Experiment Video

Updated: Apr 26, 2026

Isolation of High-density Lipoproteins for Non-coding Small RNA Quantification
10:39

Isolation of High-density Lipoproteins for Non-coding Small RNA Quantification

Published on: November 28, 2016

11.3K

Single-Particle Spectroscopic Chromatography Reveals Heterogeneous RNA Loading and Size Correlations in Lipid

Sixuan Li1,2, Yizong Hu1,3,4, Jinghan Lin1,4,5

  • 1Institute for NanoBioTechnology, Johns Hopkins University, Baltimore, Maryland 21218, United States.

ACS Nano
|June 5, 2024
PubMed
Summary

Researchers developed a new method to analyze lipid nanoparticles (LNPs) for RNA therapeutics. This technique reveals significant heterogeneity in LNP composition and RNA loading, offering crucial insights into LNP assembly.

Keywords:
compositional heterogeneitylipid nanoparticlesmultiparametric characterizationnanoparticle chromatographynanoparticle payloadsingle-particle spectroscopy

More Related Videos

A Quantitative Fluorescence Microscopy-based Single Liposome Assay for Detecting the Compositional Inhomogeneity Between Individual Liposomes
09:12

A Quantitative Fluorescence Microscopy-based Single Liposome Assay for Detecting the Compositional Inhomogeneity Between Individual Liposomes

Published on: December 13, 2019

7.9K
Determining Four Components in a Lipid Nanoparticle RNA Delivery System by Liquid Chromatography Combined with Evaporative Light Scattering Detector
08:54

Determining Four Components in a Lipid Nanoparticle RNA Delivery System by Liquid Chromatography Combined with Evaporative Light Scattering Detector

Published on: May 30, 2025

405

Related Experiment Videos

Last Updated: Apr 26, 2026

Isolation of High-density Lipoproteins for Non-coding Small RNA Quantification
10:39

Isolation of High-density Lipoproteins for Non-coding Small RNA Quantification

Published on: November 28, 2016

11.3K
A Quantitative Fluorescence Microscopy-based Single Liposome Assay for Detecting the Compositional Inhomogeneity Between Individual Liposomes
09:12

A Quantitative Fluorescence Microscopy-based Single Liposome Assay for Detecting the Compositional Inhomogeneity Between Individual Liposomes

Published on: December 13, 2019

7.9K
Determining Four Components in a Lipid Nanoparticle RNA Delivery System by Liquid Chromatography Combined with Evaporative Light Scattering Detector
08:54

Determining Four Components in a Lipid Nanoparticle RNA Delivery System by Liquid Chromatography Combined with Evaporative Light Scattering Detector

Published on: May 30, 2025

405

Area of Science:

  • Biotechnology
  • Nanotechnology
  • Pharmaceutical Sciences

Background:

  • Lipid nanoparticles (LNPs) are key delivery systems for RNA therapeutics.
  • Previous studies often assumed homogeneity in LNP populations, loading, and composition.
  • Characterizing LNP heterogeneity at the single-particle level has been challenging due to a lack of suitable tools.

Purpose of the Study:

  • To develop a generalizable strategy for dissecting multicomponent LNP assembly complexities.
  • To create a high-throughput platform for characterizing physicochemical properties of LNPs at the single-particle level.
  • To investigate LNP heterogeneity, including population identity, size, RNA loading, and lipid composition.

Main Methods:

  • An integrated spectroscopy-chromatography approach was developed.
  • The platform couples cylindrical illumination confocal spectroscopy (CICS) with single-nanoparticle free solution hydrodynamic separation (SN-FSHS).
  • This method simultaneously profiles population identity, hydrodynamic size, RNA loading, and lipid distributions in LNPs.

Main Results:

  • The platform successfully distinguished seven distinct LNP populations in a benchmark siRNA LNP formulation.
  • Quantitative characterization of size distribution and RNA loading levels across wide ranges was achieved.
  • Crucially, composition-size correlations were resolved, revealing heterogeneity in RNA packing density and size-dependent loading.

Conclusions:

  • The developed SN-FSHS-CICS analysis provides critical insights into LNP heterogeneity.
  • Significant variations in RNA packing density and size-dependent loading were observed.
  • These findings suggest kinetics-driven assembly mechanisms are responsible for RNA LNP formation.